We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Trials definition

Trials and “Tests” shall mean such trials and tests as are provided for in these conditions of contract and described in the specification and shall include all other tests to be carried out as per the requirement of the ‘employer’.
Trials are controlled, interventional clinical studies in patients of products that have been provided marketing authorization by both the Food and Drug Administration and the European Medicines Agency; “trials” do not include other studies such as phase 1 clinical investigations of drugs or biological products subject to Food and Drug Administration or European Medicines Agency regulations in healthy volunteers or pre-clinical studies. The Data to be provided is intended to be completely de- identified consistent with the HIPAA privacy standards for de-identification set forth at 45 CFR § 164.514. Such Data shall not be modified or redacted by Yale or Data User (except with regards to de-identification) and any attempts to identify patients or providers or to suggest the identity of patients or providers are prohibited by this Agreement. Yale and XXXXXXX make no guarantee the data will meet researchers’ needs for analyses outlined in the Research Proposal.
Trials and "Tests" shall mean such trials and tests as are provided for in these conditions of contract and described in the specification and shall include all other tests to be carried out as per the requirement of the ‘employer’. “Approved" or "Approval" shall mean approval in writing.

Examples of Trials in a sentence

  • Subject to the provisions of this Section 6.3 (Clinical Trial Disclosures), as between the Parties, Novartis shall have the sole right to publicly disclose the existence of, and the results from, any Clinical Trials (including the Licensor Clinical Trial) conducted under this Agreement in accordance with Applicable Laws and its standard policies.

  • ARS shall consult with Company either directly or through the JSC regarding, and keep Company regularly informed of, the conduct of Collaborative Development Activities, including such Clinical Trials, in or for the Company Territory, including material submissions by or on behalf of Company to Regulatory Authorities as sponsor of any such Clinical Trials.

  • Without limiting the foregoing, GenFleet will provide to Verastem all documentation relating to pre-clinical and Clinical Trials with respect to the Licensed Compounds and Licensed Products, including all necessary documentation attesting to GenFleet’s (or its Affiliates’ or Sublicensees’) compliance with GCP, GLP, and GMP filing requirements in the Territory or the Retained Territory, on a schedule required to meet Verastem’s applicable submission timelines.

  • Verastem has obtained all necessary authorizations, consents and approvals of any Third Party that is required to be obtained by it for, or in connection with, the transactions contemplated by this Agreement, or for the performance by it of its obligations under this Agreement, except as may be required to Develop (including to conduct Clinical Trials or to seek or obtain Regulatory Approvals or applicable Regulatory Materials), or to Manufacture, Commercialize, or otherwise Exploit Compounds or Products.

  • The JDC shall, among other activities, discuss and agree the protocols for Clinical Trials for Products in the Company Territory conducted pursuant to this Agreement.


More Definitions of Trials

Trials are controlled, interventional clinical studies in patients of medical device or diagnostic products that have been provided any necessary authorization from 2014 going forward to allow the marketing of the product under both the United States and European Union medical device legislative frameworks. “Trials” do not include the following: (i) studies that were initiated prior to the effective date of the registration requirements for “applicable device clinical trials” under Title VIII of the Food and Drug Administration Act of 2007 (FDAAA); or (ii) studies that are not considered “applicable device clinical trials” under FDAAA, including but not limited to a small clinical trial to determine the feasibility of a device or a clinical trial to test prototype devices where the primary outcome measure relates to feasibility and not to health outcomes; or (iii) pre-clinical studies. The Data to be provided is intended to be completely de-identified consistent with the HIPAA privacy standards for de-identification set forth at 45 CFR § 164.514. Such Data shall not be modified or redacted by Yale or Data User (except with regards to de- identification) and any attempts to identify patients or providers or to suggest the identity of patients or providers are prohibited by this Agreement. Yale and MDDGS, acting on behalf of the Xxxxxxx & Xxxxxxx Family of Medical Device Companies, make no guarantee the data will meet researchers’ needs for analyses outlined in the Research Proposal.
Trials and "Tests" shall mean such trials and tests as are provided for in these
Trials means any and all trials carried out on Products or any of the raw materials set out in Schedule 2 by or for Phytopharm on human and/or animal subjects.
Trials means all comparative studies of health interventions, not just ones conducted in a clinical
Trials means the clinical trials to establish the safety and efficacy of PAS required to get product approval for marketing a new drug in the US, EU and elsewhere;
Trials means Phase I, Phase II, Phase III, and [*] Trial, as applicable.”
Trials means the granting of a fee-free period by a Redistributor or Other Redistributor and its Affiliates to its End Users in respect of access to Real Time Data. Free trials are permitted once per twelve (12) month calendar period; Redistributors or Other Redistributors seeking to offer free trials to prospective End Users must implement technical and procedural controls to prevent them repeatedly signing-up for free trials. For the avoidance of doubt, the Redistributor and its Affiliates shall be entitled to permit their End Users to trial the Redistributor Products at their sole discretion and without any restrictions provided such trials do not include access to any NSE Real Time Data.